Literature DB >> 10580030

Heterocyclic amine content of cooked meat and risk of prostate cancer.

A E Norrish1, L R Ferguson, M G Knize, J S Felton, S J Sharpe, R T Jackson.   

Abstract

BACKGROUND: Some epidemiologic studies have described positive associations between prostate cancer risk and meat consumption, but underlying mechanisms have not been identified. Heterocyclic amines are mutagens formed during the cooking of meat. Well-done meat has been associated with increased risks of colorectal and breast cancers in humans. This study examined associations between prostate cancer risk and 1) estimated daily intake of heterocyclic amines from cooked meat and 2) level of cooked-meat doneness.
METHODS: A population-based, case-control study involving 317 case patients with prostate cancer and 480 age-matched control subjects was carried out in Auckland, New Zealand. Levels of meat doneness and daily intake of heterocyclic amines were determined from self-reported dietary data and experimentally measured heterocyclic amine levels in locally sourced meat samples cooked under controlled conditions to varying degrees of doneness.
RESULTS: The heterocyclic amines found in the highest concentrations in meat samples were 2-amino-1,6-dimethylfuro[3,2-e]imidazo[4,5-b]pyridine (IFP) and 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) from well-done chicken and pork and very well-done beefsteak. Meat doneness was weakly and inconsistently associated with prostate cancer risk for individual types of meat, but increased risk was observed for well-done beefsteak (relative risk = 1.68; 95% confidence interval = 1.02-2.77; two-sided P for trend =.03). A weak positive gradient of increased risk was associated with estimated daily exposure to IFP but not with the other major heterocyclic amines.
CONCLUSIONS: Meat doneness and estimated intake of heterocyclic amines from cooked meat were not clearly associated with prostate cancer risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580030     DOI: 10.1093/jnci/91.23.2038

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  29 in total

Review 1.  Nutrigenomics: integrating genomic approaches into nutrition research.

Authors:  Lynnette R Ferguson
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  Vitamin C and Vitamin E Mitigate the Risk of Pancreatic Ductal Adenocarcinoma from Meat-Derived Mutagen Exposure in Adults in a Case-Control Study.

Authors:  Donghui Li; Hongwei Tang; Peng Wei; Jiali Zheng; Carrie R Daniel; Manal M Hassan
Journal:  J Nutr       Date:  2019-08-01       Impact factor: 4.798

3.  Development of animal models underlining mechanistic connections between prostate inflammation and cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  World J Clin Oncol       Date:  2013-02-10

Review 4.  Inflammation in prostate carcinogenesis.

Authors:  Angelo M De Marzo; Elizabeth A Platz; Siobhan Sutcliffe; Jianfeng Xu; Henrik Grönberg; Charles G Drake; Yasutomo Nakai; William B Isaacs; William G Nelson
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

Review 5.  Well-done meat intake, heterocyclic amine exposure, and cancer risk.

Authors:  Wei Zheng; Sang-Ah Lee
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  Consumption of deep-fried foods and risk of prostate cancer.

Authors:  Marni Stott-Miller; Marian L Neuhouser; Janet L Stanford
Journal:  Prostate       Date:  2013-01-17       Impact factor: 4.104

7.  Intake of Meat Mutagens and Risk of Prostate Cancer in a Cohort of U.S. Health Professionals.

Authors:  Sabine Rohrmann; Katharina Nimptsch; Rashmi Sinha; Walter C Willett; Edward L Giovannucci; Elizabeth A Platz; Kana Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-29       Impact factor: 4.254

8.  Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.

Authors:  Stella Koutros; Sonja I Berndt; Rashmi Sinha; Xiaomei Ma; Nilanjan Chatterjee; Michael C R Alavanja; Tongzhang Zheng; Wen-Yi Huang; Richard B Hayes; Amanda J Cross
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

9.  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in benign prostate and subsequent risk for prostate cancer.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Sheri Trudeau; Andrew Rundle; Satoru Takahashi; Tomoyuki Shirai; Benjamin A Rybicki
Journal:  Int J Cancer       Date:  2013-03-09       Impact factor: 7.396

10.  Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

Authors:  You-Cheng Lin; Xun Wu; Xue-Qiong Zhou; Rui Ren; Ze-Xuan Su; Chun-Xiao Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.